ql1706
mAbexperimental
Clinical trial activity
122 trials · 54 clinical orgs · 0 marketing orgs
Phase 1
15
Phase 2
107
Phase 3
11
Phase 4
1
Earliest trial started Mar 31, 2020 (NCT04296994)
Timeline
Indications
Studied for
- Bevacizumab · Phase 4
- Biliary Tract Neoplasms · Phase 2
- Breast Neoplasms · Phase 2/Phase 3
- Carcinoma, Hepatocellular · Phase 2/Phase 3
- Carcinoma, Non-Small-Cell Lung · Phase 3
- Chemoradiotherapy · Phase 2
- Cholangiocarcinoma · Phase 2
- Colonic Neoplasms · Phase 3
- Colorectal Neoplasms · Phase 3
- Drugs, Investigational · Phase 2
- Drug Therapy · Phase 2
- Endometrial Neoplasms · Phase 2
- Esophageal Neoplasms · Phase 2
- Esophageal Squamous Cell Carcinoma · Phase 2
- General Surgery · Phase 2
- Immunotherapy · Phase 2
- Liver Neoplasms · Phase 2
- Lung Neoplasms · Phase 3
- Melanoma · Phase 4
- Mesothelioma · Phase 1/Phase 2
- Mesothelioma, Malignant · Phase 1/Phase 2
- Nasopharyngeal Carcinoma · Phase 3
- Nasopharyngeal Neoplasms · Phase 3
- Neoadjuvant Therapy · Phase 2/Phase 3
- Neoplasm Recurrence, Local · Phase 2
- Neoplasms · Phase 2
- Ovarian Neoplasms · Phase 3
- Ovulation Induction · Phase 2
- Pancreatic Neoplasms · Phase 2
- Radiotherapy · Phase 2
- Rectal Neoplasms · Phase 2
- Sarcoma · Phase 2
- Small Cell Lung Carcinoma · Phase 3
- Squamous Cell Carcinoma of Head and Neck · Phase 2
- Stomach Neoplasms · Phase 2
- Uterine Cervical Neoplasms · Phase 3
Mechanism of action
- Programmed cell death protein 1INHIBITOR
PDCD1 inhibitor
- Cytotoxic T-lymphocyte protein 4INHIBITOR
CTLA4 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07277972 | Phase 2 | Feb 15, 2026 | Tianjin Medical University |
| NCT07263360 | Phase 2 | Feb 1, 2026 | Tianjin Medical University |
| NCT07291401 | Phase 2 | Jan 1, 2026 | Xiamen University |
| NCT07229872 | Phase 2 | Dec 31, 2025 | Harbin Medical University |
| NCT07229846 | Phase 2 | Dec 31, 2025 | Harbin Medical University |
| NCT07272590 | Phase 1/Phase 2 (Phase 2) | Dec 30, 2025 | Qilu Pharmaceutical Co., Ltd. |
| NCT07187674 | N/A | Dec 30, 2025 | Harbin Medical University |
| NCT07268131 | N/A | Dec 20, 2025 | Fudan University |
| NCT07246317 | Phase 2 | Dec 15, 2025 | Tianjin Medical University |
| NCT07256236 | Phase 2 | Dec 15, 2025 | Fujian Medical University |
| NCT07200947 | Phase 2 | Dec 1, 2025 | Chinese Academy of Medical Sciences, Hebei University, Peking University |
| NCT07129018 | Phase 2 | Nov 30, 2025 | Eastern Hepatobiliary Surgery Hospital, Huazhong University of Science and Technology |
| NCT07286240 | Phase 2 | Nov 15, 2025 | Guangzhou Medical University |
| NCT07232654 | Phase 2 | Nov 10, 2025 | Chinese Academy of Medical Sciences |
| NCT07178171 | Phase 1 | Nov 6, 2025 | Qilu Pharmaceutical Co., Ltd., Xijing Hospital |
| NCT07291947 | Phase 1/Phase 2 (Phase 2) | Nov 4, 2025 | Sichuan University |
| NCT07179900 | Phase 2 | Oct 31, 2025 | Hebei University |
| NCT07139041 | Phase 2 | Oct 31, 2025 | Huazhong University of Science and Technology |
| NCT07286253 | Phase 2 | Oct 28, 2025 | Guangzhou Medical University |
| NCT07256782 | Phase 1/Phase 2 (Phase 2) | Oct 24, 2025 | Qilu Pharmaceutical Co., Ltd. |
Showing 20 of 122 trials
Page 1 / 7
Organizations
Research & Development (54)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Qilu Pharmaceutical Co., Ltd. | For profit | 32 | 22 | 4 | 2020 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 12 | 11 | 2 | 2025 |
| Sun Yat-Sen University | Academic/Hospital | 12 | 7 | 3 | 2021 |
| Tianjin Medical University | Academic/Hospital | 10 | 9 | 1 | 2022 |
| Fudan University | Academic/Hospital | 9 | 7 | 3 | 2023 |
| Hebei University | Academic/Hospital | 8 | 6 | 3 | 2025 |
| Huazhong University of Science and Technology | Academic/Hospital | 8 | 5 | 3 | 2022 |
| Peking University | Academic/Hospital | 6 | 3 | 2 | 2025 |
| Shandong University | Academic/Hospital | 6 | 5 | 1 | 2025 |
| Nanjing Medical University | Academic/Hospital | 5 | 5 | 1 | 2025 |
| Fujian Medical University | Academic/Hospital | 4 | 4 | 1 | 2025 |
| Harbin Medical University | Academic/Hospital | 4 | 3 | 2 | 2025 |
| Jiao Tong University | Academic/Hospital | 4 | 3 | 2 | 2025 |
| Henan Medical University | Academic/Hospital | 3 | 1 | 2 | 2025 |
| Jiangsu Cancer Institute & Hospital | Academic/Hospital | 3 | 1 | 2 | 2025 |
| Nanchang University | Academic/Hospital | 3 | 3 | 1 | 2025 |
| Shandong Provincial Hospital | Academic/Hospital | 3 | 2 | 1 | 2025 |
| Zhengzhou University | Academic/Hospital | 3 | 1 | 2 | 2025 |
| Anhui Medical University | Academic/Hospital | 2 | 2 | 1 | 2025 |
| Eastern Hepatobiliary Surgery Hospital | Academic/Hospital | 2 | 1 | 1 | 2025 |
54 organizations
Page 1 / 3